KTN's online platform helps you to make the connections you need

 

The Knowledge Transfer Network (KTN) has refreshed its online platform to intelligently connect you to relevant events, funding, thought pieces and specialist staff to help your business innovate and grow.

You can discover content using your area of interest, from Defence Security to transport; from space to health – all major UK economic sectors are covered. Once you have selected your interests, using our intelligent tagging system, we will then display rich and relevant content related to your area, often from surprising sources.

An example might be new satellite technology from the space sector that is applicable in the agri-food sector. KTN-UK.co.uk will help you form these unusual and valuable connections.

All content on the platform has been carefully curated by our team of innovation specialists – not by an automated algorithm – so you can be confident that KTN is connecting you to the most relevant cutting-edge information.

 

The move also marks a closer alignment with our main funder, Innovate UK , with the website branding making a clear visual link. Knowledge Transfer Network is Innovate UK's innovation network partner, and also works with other funders to provide innovation networking services and fulfil our mission to drive UK growth.

We link new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From agri-food to autonomous systems and from energy to design, KTN combines expertise in all sectors with the ability to cross boundaries. Connecting with KTN can lead to potential partners, horizon-expanding events and innovation insights relevant to your needs.

Visit our people pages to connect directly with expertise in your sector.

Visit the KTN refreshed online platfom here

Entries with Sector Types Bioscience .

Open Innovate UK Funding competition

Innovate UK is to invest up to  £15 million  in innovation projects in manufacturing and/or materials. These projects will focus on identified technical or commercial challenges which are set out in the competition scope. The aim of this competition is to stimulate and broaden innovation in manufacturing and materials.  Projects need to be led by a business and must...
Read More About Open Innovate UK Funding competition »

Opportunities for IB & SynBio in the New Innovate UK Delivery Plan

Innovate UK has recently published its new  Delivery Plan,  outlining the main ways in which it will invest around £561M in helping businesses to innovate and grow in the financial year 2016 to 2017, including: two broad Health and Life Sciences competitions two broad Manufacturing and Materials competitions two ‘open’ funding competitions...
Read More About Opportunities for IB & SynBio in the New Innovate UK Delivery Plan »

Overcoming Cellular Barriers: Implications for Industrial Biotechnology

Overcoming Cellular Barriers: Implications for Industrial Biotechnology July 6th and 7th 2016, Birmingham Hilton Metropole The function of membranes in bacterial, yeast and mammalian cell factories are an important but underappreciated parameter in optimizing recombinant protein quality and yields.  In addition, the delivery of a therapeutic protein to its target...
Read More About Overcoming Cellular Barriers: Implications for Industrial Biotechnology »

MRC announces cross-council awards worth nearly £10m to tackle antibiotic resistance

Three large collaborative grants, totalling £9.5m, have been announced by the MRC as part of a cross-council initiative to tackle antimicrobial resistance (AMR). The awards together mark one of the biggest investments into AMR since the initiative launched and will use new technology to exploit natural compounds, develop a tool to offer better and faster diagnostics and explore how the...
Read More About MRC announces cross-council awards worth nearly £10m to tackle antibiotic resistance »

Oxstem closes record £16.9M fundraising round to design Stem Cell drugs to treat age-related disease

One of the most ambitious Oxford spinouts to date is on route to becoming a powerhouse in age-related regenerative medicine, developing drugs which can treat cancer, neurodegenerative diseases, heart failure, macular degeneration and other major age-related conditions. OxStem has raised a record £16.9m, and established strategic partnerships with world class biotechnology companies and...
Read More About Oxstem closes record £16.9M fundraising round to design Stem Cell drugs to treat age-related disease »

MedImmune and Regeneron Enter into Licensing Agreement for the Development of Antibody Drug Conjugates to Treat Cancer

MedImmune, the global biologics research and development arm of AstraZeneca and Regeneron Pharmaceuticals, Inc., today announced that they have entered into a licensing agreement under which Regeneron will use MedImmune’s pyrrolobenzodiazepine (PBD)-based warhead and linker technology to produce antibody-drug conjugates (ADCs) as potential cancer treatments. Regeneron will have exclusive...
Read More About MedImmune and Regeneron Enter into Licensing Agreement for the Development of Antibody Drug Conjugates to Treat Cancer »

Universal flu vaccine under development by Oxford spinout Vaccitech

Universal flu vaccine developed at Oxford already showing promise in Phase II clinical trials Large investment of £10m from Oxford Sciences Innovation Further programs include vaccines to boost cancer immunotherapies Oxford spin out company Vaccitech has launched today with £10m seed investment to develop a universal flu vaccine already showing promise in clinical...
Read More About Universal flu vaccine under development by Oxford spinout Vaccitech »

Funding competition: manufacturing and materials

Innovate UK is to invest up to £15 million in innovation projects in manufacturing and/or materials. Innovate UK is to invest up to £15 million in innovation projects in manufacturing and/or materials. These projects will focus on identified technical or commercial challenges. We will fund projects that aim to lead to increased UK SME productivity, competitiveness and growth. ...
Read More About Funding competition: manufacturing and materials »

Innovate UK invests £561 million to back cutting-edge UK firms

Delivery Plan for the year 2016 to 2017 shows how Innovate UK will invest £561 million, with a more focused approach to innovation support. Innovate UK is to invest £561 million in innovation over the next 12 months and take a more focused and efficient approach to supporting innovative UK companies. The delivery plan for the year 2016 to 2017 includes: a new sector focus that is...
Read More About Innovate UK invests £561 million to back cutting-edge UK firms »

Blueberry Therapeutics raises £3M to progress the development of its lead topical antifungal

Blueberry Therapeutics today announced that it has raised £3 million to progress the development of its topical fungal infection therapies into human clinical trials. The investment was led by the GM&C Life Sciences Fund, managed by Catapult Ventures, and included participation from San Francisco-based InClin Investments, as well as a number of private investors. The investment will...
Read More About Blueberry Therapeutics raises £3M to progress the development of its lead topical antifungal »

EuropaBio launches the Most Innovative European Biotech SME Awards 2016

EuropaBio, the European Association for Bioindustries, is inviting small and medium sized biotech companies (SMEs) across Europe to apply for the 7th edition of the Most Innovative European Biotech SME Award – a unique annual initiative recognising biotech innovation and its contribution to society. Depending on their field of activity, SMEs can apply in 3 categories: healthcare,...
Read More About EuropaBio launches the Most Innovative European Biotech SME Awards 2016 »

Oxford Biomedica updates on LentiVector

Oxford BioMedica plc, a leading gene and cell therapy company, today announces that new data has been presented from two clinical studies indicating ground-breaking long-term four-year sustained and, in one of the studies, dose-dependent gene expression with the Company’s LentiVector® delivery platform. On 5 May 2016, Professor Stéphane Palfi presented a poster on OXB-101, a gene...
Read More About Oxford Biomedica updates on LentiVector »

3G (Genetics and Genomics for the Third Generation) Conference

3G (Genetics and Genomics for the Third Generation) Conference 22/06/2016 Cardiff A conference primarily for members of the public over the age of fifty about genetics and genomics-related research and advances. There will be a programme of short talks from expert speakers, as well as interactive stands for the public to enjoy. Area of innovation being demonstrated ...
Read More About 3G (Genetics and Genomics for the Third Generation) Conference »

Programming Inititative on Antimicrobial Resistance (JPIAMR) call now open

The Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) has opened its 4th Joint Call “Call for Transnational Networks/Working Groups within the Joint Programming Inititative on Antimicrobial Resistance ” , in partnership with 8 European countries (Belgium, France, Germany, Netherlands, Norway, Spain, Sweden and the UK), and Canada. The call sets out to assemble...
Read More About Programming Inititative on Antimicrobial Resistance (JPIAMR) call now open »

BIA leads international call to review US court decision

The UK BioIndustry Association (BIA) has urged the US Supreme Court to review a decision of a lower court that could hinder the development of new diagnostics and life-saving medicines. The UK BioIndustry Association has filed an Amicus – or friend of the court – Brief supported by an international coalition of biotechnology trade organisations arguing that the decision of the US Federal...
Read More About BIA leads international call to review US court decision »

Scotland: Getting Investment Ready

Quantiply, the investment-readiness and access to finance platform, invite you to their 'Getting Investment Ready' workshop at 2pm on 26th April in Edinburgh at Informatics Forum. The workshop will help startups put their best foot forward when going for investment. From communications and messaging to R&D tax credits and legal services, the workshop highlights what investors want...
Read More About Scotland: Getting Investment Ready »

For the eyes of highly innovative SMEs with global ambitions only...

As part of the  Horizon 2020 programme , the European Commission is hand-picking potentially disruptive businesses to invest in and support as part of the SME Instrument. Your business could receive up to €2.5 million in funding, and  world-class business coaching .  Topics to be funded in 2016 and 2017 are available here: ...
Read More About For the eyes of highly innovative SMEs with global ambitions only... »

Johnson Matthey and Domainex Collaborate to Enhance Discovery and Development Services for UK Pharma, Biotech and Academia

Johnson Matthey, a leading provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies and Domainex Ltd. (Cambridge, UK), a small-molecule drug discovery company, have announced a collaboration to provide integrated small molecule pharmaceutical discovery and development services. The focus will be on providing academic institutes, biotechnology...
Read More About Johnson Matthey and Domainex Collaborate to Enhance Discovery and Development Services for UK Pharma, Biotech and Academia »

Heptares and Kymab enter Strategic Collaboration to Discover, Develop and Commercialise Novel Antibody Therapeutics

Heptares Therapeutics, the wholly-owned subsidiary of Sosei Group Corporation, and Kymab Limited, a leading human monoclonal antibody biopharmaceutical company, have entered into a strategic collaboration to discover, develop and commercialise novel antibody therapeutics targeting a number of G protein-coupled receptors (GPCR) with an initial focus on immuno-oncology. Immuno-oncology is...
Read More About Heptares and Kymab enter Strategic Collaboration to Discover, Develop and Commercialise Novel Antibody Therapeutics »

Planned Restriction On Use of Triton X-100

The EU Commission plans to add 4-tert-OPnEO (Triton X-100) to the list of chemicals on Annex XIV of the Regulation. Once included in this Annex, a substance cannot be placed on the market for a use or used after a given date (approx. 2020 in this case) unless the companies concerned are granted an authorisation for the specific use(s). To help in advocacy to UK Government on this issue,...
Read More About Planned Restriction On Use of Triton X-100 »

New Chief Executive Officer of the Precision Medicine Catapult

The Precision Medicine Catapult, the UK's innovation centre for precision medicine, announces it has appointed Dr Belinda Quinn as its new Chief Executive Officer. Belinda has been working as Chief Clinical Officer of the Precision Medicine Catapult over the past six months, formulating and landscaping Precision Medicine opportunities across the UK. She has played a pivotal leadership...
Read More About New Chief Executive Officer of the Precision Medicine Catapult »

Universal Biotech Innovation Prize 2016 Now Open

The Universal Biotech Innovation Prize aims to promote innovation in the field of Life Sciences. The Prize targets new drugs, medical devices, applications/platforms and technologies in the field of diagnostic, therapeutic and e-health solutions. The product or service must be under development at the time of submission. Participation is open to academic researchers in the field of...
Read More About Universal Biotech Innovation Prize 2016 Now Open »

New gene therapy for the treatment of children with ultra-rare immune disorder recommended for approval

GlaxoSmithKline has received a thumbs-up from a European Medicines Agency committee for its groundbreaking new gene therapy treatment--but it's already thinking about pricing as it gears up for a final European approval in the coming months. The CHMP--the safety and efficacy arm of the European regulator--recommended approval of GSK's new drug Strimvelis on Friday to treat the incredibly...
Read More About New gene therapy for the treatment of children with ultra-rare immune disorder recommended for approval »

MMIP update from Ian McCubbin

Welcome to my first Medicines Manufacturing Industry Partnership (MMIP) update. Throughout 2016 we intend to share more of our activities as we build the medicines manufacturing community voice and promote the drive for growth of medicines manufacturing in the UK. As a way to help us to connect with you and give more detail about what we do and our work, we have prepared with the...
Read More About MMIP update from Ian McCubbin »

KTN "Current Funding Opportunities through EU SME Instrument" Webinar Recording & Slides now online

KTN Webinar Recording & Slide pack for last months "Current Funding Opportunities through EU SME Instrument in support of manufacturing for cell based products" is now avaliable to view below. 160318 WEBINAR Current Funding Opportunities through EU SME Download the slides here ...
Read More About KTN "Current Funding Opportunities through EU SME Instrument" Webinar Recording & Slides now online »
Showing 26 - 50 of 96 results.
Items per Page 25
of 4